MedPath

The Effect of Concentrated Pomegranate Juice Consumption on Lipid Profile and Inflammatory Factors in Patients With Type 2 Diabetes

Not Applicable
Conditions
Type 2 Diabetes
Interventions
Other: 50 gr concentrated pomegranate juice
Registration Number
NCT02024516
Lead Sponsor
Ahvaz Jundishapur University of Medical Sciences
Brief Summary

The aim of this study is to examine the effects of concentrated pomegranate juice on serum lipid profile and some inflammatory factors in patients with type 2 diabetes. Forty patients aged between 25-60 years old from both sexes are recruited. Patients consume 50gr/day concentrated pomegranate juice for 4 weeks. Anthropometric and blood pressure measurements, 3-days food-record questionnaire ,physical activity and fasting blood samples were collected at the beginning and at the end of the study. Fasting blood sugar, lipid profile, TNF- a, IL-6,hs -CRP and adiponectin levels are measured. LDL are calculated by formula. The participants are asked not to change their regular diet, medicine and activity during the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • male or female 25 to 60 years old
  • having type 2 diabetes for at least 6 month
Exclusion Criteria
  • pregnancy
  • lactation
  • cardiac disease
  • hepatic disease
  • respiratory disease
  • chronic renal diseases
  • acute or chronic inflammation
  • retinopathy
  • intake of antioxidant supplement
  • insulin therapy
  • sensitivity to concentrated pomegranate juice
  • change oral drug for controlling blood glucose

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
50 gr concentrated pomegranate juice50 gr concentrated pomegranate juice-
Primary Outcome Measures
NameTimeMethod
adiponectin changeBaseline and after 4 weeks
Triglyceride changeBaseline and after 4 weeks
HDL- Cholesterol changeBaseline and after 4 weeks
Total Cholesterol changeBaseline and after 4 weeks
hsCRP changeBaseline and after 4 weeks
TNF- α changeBaseline and after 4 weeks
IL-6 changeBaseline and after 4 weeks
LDL- Cholesterol changeBaseline and after 4 weeks
Secondary Outcome Measures
NameTimeMethod
Fasting Blood Sugar changebaseline and after 4 weeks
Body Mass Index changebaseline and after 4 weeks
Blood Pressure changeBaseline and after 4 weeks

Trial Locations

Locations (1)

Ahvaz Jundishapoor University of Medical Sciences

🇮🇷

Ahvaz, Khoozestan, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath